Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy.

@article{Carter1989ResultsOL,
  title={Results of local and/or systemic adjuvant therapy in the management of pathological stage C or D1 prostate cancer following radical prostatectomy.},
  author={Glendora Carter and Gary Lieskovsky and Donald G. Skinner and Zbigniew Petrovich},
  journal={The Journal of urology},
  year={1989},
  volume={142 5},
  pages={1266-70; discussion 1270-1}
}
Between 1976 and 1984, 47 of 108 patients (44%) who underwent radical retropubic prostatectomy and pelvic lymphadenectomy for clinical stage A2 or B adenocarcinoma of the prostate were found to have pathological stage C or D1 disease. A total of 31 consecutive patients with pathological stage C disease received 45 to 55 Gy. adjuvant external beam radiation postoperatively. Actuarial 5 and 10-year survival rates free of disease were 92%, with a local recurrence rate of 3% and a distant… CONTINUE READING